文献速递肝病消化道肿瘤与早癌

荧光肽在小鼠肝细胞癌模型和人类离体组织中突出微小结节

Fluorescent peptide highlights micronodules in murine hepatocellular carcinoma models and humans in vitro.
PubMed 文献 · Hepatology · 2018-05-21

研究通过噬菌体展示发现一种优先结合肝细胞癌细胞的肽,荧光标记后可在荷瘤小鼠全身注射2小时内显著聚集于肿瘤,肿瘤与周围肝组织对比度达6.5倍,有效对比持续30小时,可清晰区分肝和肺中直径0.03 cm的微小结节,并在人组织中实现肝细胞癌与瘤周组织高达10倍区分,手术导航下完全切除小鼠肿瘤,未观察到明显毒性。

要点

  • 荧光标记肽在全身注射2小时内聚集于异位和原位肝细胞癌小鼠肿瘤,肿瘤与周围肝组织对比度达6.5倍,有效对比持续30小时。
  • 该肽可在原位肝细胞癌小鼠和肝细胞癌患者中清晰区分肝和肺内直径0.03 cm的微小结节与正常组织。
  • 与吲哚菁绿相比,该荧光标记肽对肿瘤与纤维化的区分比最高达8.7倍,在人组织中实现肝细胞癌与瘤周组织高达10倍区分。

核心结论

  • 该分子可高灵敏度地将微小结节与周围组织特异性区分,为肝细胞癌的早期检测和精准手术开辟了临床可能性。

研究设计与样本

  • 通过噬菌体展示技术发现优先结合肝细胞癌细胞的肽,并在异位和原位肝细胞癌小鼠及人组织中进行荧光成像评估。

主要发现

  • 荧光标记肽在异位和原位肝细胞癌小鼠全身注射后2小时内显著聚集于肿瘤,肿瘤与周围肝组织对比度达6.5倍,有效对比持续30小时。
  • 在原位肝细胞癌小鼠和肝细胞癌患者中,该荧光标记肽可清晰区分肝和肺内直径0.03 cm的微小结节与正常组织。
  • 与吲哚菁绿相比,该荧光标记肽对肿瘤与纤维化的区分比最高达8.7倍。
  • 该肽在人组织中实现肝细胞癌与瘤周组织高达10倍区分,并在手术导航下实现肝细胞癌小鼠肿瘤完全切除。
  • 全身治疗后未观察到行为或活动异常,表明无明显毒性;该肽在血清中代谢半衰期约为4小时。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Early detection and clear delineation of microscopic lesions during surgery are critical to the prognosis and survival of patients with hepatocellular carcinoma (HCC), a devastating malignancy without effective treatments except for resection. Tools to specifically identify and differentiate micronodules from normal tissue in HCC patients can have a positive impact on survival. Here, we discovered a peptide that preferentially binds to HCC cells through phage display. Significant accumulation of the fluorescence-labeled peptide in tumor from ectopic and orthotopic HCC mice was observed within 2 hours of systemic injection. Contrast between tumor and surrounding liver is up to 6.5-fold, and useful contrast lasts for 30 hours. Micronodules (0.03 cm in diameter) in liver and lung can clearly be distinguished from normal tissue with this fluorescence-labeled peptide in orthotopic HCC mice and HCC patients. Compared to indocyanine green, a Food and Drug Administration-approved imaging contrast agent, an up to 8.7-fold higher differentiation ratio of tumor to fibrosis is achieved with this fluorescence-labeled peptide. Importantly, this peptide enables up to 10-fold differentiation between HCC and peritumoral tissue in human tissues and the complete removal of tumor in HCC mice with surgical navigation. No abnormalities in behavior or activity are observed after systemic treatment, indicating the absence of overt toxicity. The peptide is metabolized with a half-life of approximately 4 hours in serum. CONCLUSION: Our findings demonstrate that micronodules can be specifically differentiated with high sensitivity from surrounding tissue with this molecule, opening clinical possibilities for early detection and precise surgery of HCC. (Hepatology 2018).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Jing R, Zhou X, Zhao J, et al. Fluorescent peptide highlights micronodules in murine hepatocellular carcinoma models and humans in vitro. Hepatology. 2018. PMID: 29405333. doi:10.1002/hep.29829

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。